Stocks to sell

“Sell the news” seemed to be the market’s response to AMC Entertainment’s (NYSE:AMC) latest earnings report. After the close on Nov. 8, the movie theater chain reported higher-than-expected revenue ($763 million versus $708 million consensus) and a narrower-than-expected per-share loss (44 cents versus 53 cents consensus), for the quarter ending Sept. 30. Yet, it did not
0 Comments
ContextLogic (NASDAQ:WISH) is set to announce its third-quarter earnings today under a new CFO. But there probably won’t be a lot to celebrate when the report is released. Ultimately, that means investing in WISH stock isn’t going to be worthwhile. Source: sdx15 / Shutterstock.com That said, ContextLogic will remain a popular choice for risk-tolerant retail
0 Comments
InvestorPlace columnist Larry Ramer recently argued that Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) and Qualcomm (NASDAQ:QCOM) would become potential buyers of BlackBerry (NYSE:BB) once they become more familiar with the company’s QNX operating system. Ramer believes that’s a good reason to buy BB stock.     Source: Shutterstock “[C]ompanies can’t hire enough cybersecurity experts to protect themselves from ruinous hacks,
0 Comments
Palantir Technologies (NYSE:PLTR) hasn’t fully recovered since pulling back with the overall market in late September. But PLTR stock has still managed to slowly move higher in recent weeks. Source: Ascannio / Shutterstock.com To some extent, this uptrend makes sense. After all, the “story” behind this stock remains intact. The company has continued to post strong
0 Comments
If you’ve read my prior articles on Ocugen (NASDAQ:OCGN), you know full well my heavily bearish view about OCGN stock. What’s the story here? The company is trying to bring Covaxin, a Covid-19 vaccine candidate developed by India’s Bharat Biotech, to the U.S. and Canada. Source: shutterstock.com/PhotobyTawat So far, it’s made little progress obtaining Emergency
0 Comments
Over the trailing year, a majority of my single-company opinions have been at least middle of the road for obvious reasons. Although I do have broader economic concerns, benchmark indices have proven resilient. So, my headline to consider exiting Novavax (NASDAQ:NVAX) stock might seem controversial. Source: Ascannio/Shutterstock.com However, I genuinely believe taking the green ink
0 Comments
Peloton Interactive (NASDAQ:PTON) was a pandemic favorite. With gyms shut down and people stuck at home, they snapped up Peloton’s pricey internet-connected exercise bikes and treadmills. But in the spring, with gyms reopening and the outdoors beckoning, sales quickly dropped off. Then things got even worse for PTON stock. Source: JHVEPhoto / Shutterstock.com It put
0 Comments